<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Granulocyte colony-stimulating factor (G-CSF) is a neuroprotective agent and activates endothelial proliferation and bone marrow stem cell mobilization </plain></SENT>
<SENT sid="1" pm="."><plain>We studied the effect of G-CSF on <z:mpath ids='MPATH_177'>angiogenesis</z:mpath> and neurological recovery after focal <z:hpo ids='HP_0002637'>cerebral ischemia</z:hpo> </plain></SENT>
<SENT sid="2" pm="."><plain>After the induction of transient focal <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> in rats, G-CSF (50 micro/day, i.p.) or PBS was administered for 3 days </plain></SENT>
<SENT sid="3" pm="."><plain>We evaluated the functional recovery, <z:mpath ids='MPATH_124'>infarct</z:mpath> volume, inflammatory infiltration, blood-brain barrier (<z:chebi fb="2" ids="33602">BBB</z:chebi>) disruption, hemispheric <z:mpath ids='MPATH_127'>atrophy</z:mpath>, protein expressions of endothelial nitric <z:chebi fb="177" ids="25741,29356">oxide</z:chebi> synthase (eNOS) and angiopoietins, and the therapeutic time window of G-CSF administration </plain></SENT>
<SENT sid="4" pm="."><plain>We then analyzed endothelial cell proliferation, the vascular surface area, the number of branch points, and the vascular length </plain></SENT>
<SENT sid="5" pm="."><plain>G-CSF treatment improved behavioral recovery and reduced the <z:mpath ids='MPATH_124'>infarct</z:mpath> volume, the inflammatory infiltration, the <z:chebi fb="2" ids="33602">BBB</z:chebi> disruption, and the hemispheric <z:mpath ids='MPATH_127'>atrophy</z:mpath> </plain></SENT>
<SENT sid="6" pm="."><plain>G-CSF injection, starting at 2 h, 1 day, or 4 days after <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e>, resulted in a better functional recovery and a greater reduction in hemispheric <z:mpath ids='MPATH_127'>atrophy</z:mpath> than injection starting at day 7 </plain></SENT>
<SENT sid="7" pm="."><plain>The vascular surface area, the vascular branch points, the vascular length, the number of BrdU(+) endothelial cells, and eNOS/angiopoietin-2 expression were significantly increased in the G-CSF group compared with the <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e>-only group </plain></SENT>
<SENT sid="8" pm="."><plain>G-CSF injection starting at 1 day induced larger endothelial proliferation compared with injection starting at 7 days </plain></SENT>
<SENT sid="9" pm="."><plain>In this study, we provide evidences that G-CSF enhances the <z:mpath ids='MPATH_177'>angiogenesis</z:mpath> and reduces the ischemic damage, which promotes the long-term functional recovery </plain></SENT>
</text></document>